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Inhibition or inactivation of InhA, a fatty acid synthase II (FASII) enzyme, leads to mycobacterial cell lysis.
To determine whether inactivation of other enzymes of the mycolic acid-synthesizing FASII complex also leads
to lysis, we characterized the essentiality of two -ketoacyl–acyl carrier protein synthases, KasA and KasB, in
Mycobacterium smegmatis. Using specialized transduction for allelic exchange, null kasB mutants, but not kasA
mutants, could be generated in Mycobacterium smegmatis, suggesting that unlike kasB, kasA is essential. To
confirm the essentiality of kasA, and to detail the molecular events that occur following depletion of KasA, we
developed CESTET (conditional expression specialized transduction essentiality test), a genetic tool that
combines conditional gene expression and specialized transduction. Using CESTET, we were able to generate
conditional null inhA and kasA mutants. We studied the effects of depletion of KasA in M. smegmatis using the
former strain as a reference. Depletion of either InhA or KasA led to cell lysis, but with different biochemical
and morphological events prior to lysis. While InhA depletion led to the induction of an 80-kDa complex
containing both KasA and AcpM, the mycobacterial acyl carrier protein, KasA depletion did not induce the
same complex. Depletion of either InhA or KasA led to inhibition of  and epoxy mycolate biosynthesis and to
accumulation of -mycolates. Furthermore, scanning electron micrographs revealed that KasA depletion
resulted in the cell surface having a “crumpled” appearance, in contrast to the blebs observed on InhA
depletion. Thus, our studies support the further exploration of KasA as a target for mycobacterial-drug
development.
The emergence of multidrug-resistant Mycobacterium tuber-
culosis has been partly responsible for the global spread of
tuberculosis (TB) in the past decade (51). There is an urgent
need to develop novel drugs that are active against M. tuber-
culosis. Existing antimycobacterial agents act either by inhib-
iting growth or by causing cell death. The antituberculosis drug
isoniazid (INH) inhibits the biosynthesis of mycolic acids, ma-
jor components of cell wall lipids, resulting in cell death by lysis
(43, 49, 50). INH inhibits InhA (1, 21, 32), an enoyl-acyl carrier
protein (ACP) reductase which is part of the multienzyme fatty
acid synthase II complex (FASII) that synthesizes the mero-
mycolate precursors of mycolic acids. Although the structures
of mycolic acids have been well characterized, the genetics and
enzymology of mycolic acid biosynthesis have only recently
begun to be elucidated (1, 2, 15, 20, 32, 36, 37, 42, 47). Myco-
bacteria, unlike most bacteria, have two fatty acid synthases.
The eukaryote-like FASI, which is a large multidomain
polypeptide containing all enzymatic functions required for de
novo fatty acid synthesis, produces in a bimodal fashion satu-
rated fatty acids of palmitate (C16:0) and tetracosanoate (C24:0)
or C26 (6, 30). FASII elongates FASI end products to form
long-chain fatty acids or meromycolates. Acyl chains bound to
an ACP are elongated by repetitive cycles of condensation,
keto reduction, dehydration, and enoyl reduction catalyzed by
a -ketoacyl-ACP synthase, a -ketoacyl-ACP reductase, a
-hydroxyacyl-ACP dehydratase, and an enoyl-ACP reductase,
respectively. The resultant meromycolate chain is then con-
densed with a C26 fatty acid to form a mycolic acid (31). In M.
tuberculosis, M. bovis, and M. smegmatis, genes known to en-
code FASII enzymes are found in two loci (2, 9, 16). One locus
is an operon which includes genes encoding two discrete -ke-
toacyl-ACP synthases (kasA and kasB) and the acyl carrier
protein (acpM). The ketoreductase (mabA) and the enoyl re-
ductase (inhA) genes are present in another operon (1, 2).
Although open reading frames encoding putative dehydratases
have been identified in mycobacterial genomes (42), their roles
in FASII have yet to be tested.
Exploiting a mutation in inhA that made the InhA protein
thermolabile, Vilche`ze et al. (47) were able to demonstrate
that the thermal inactivation of InhA was sufficient to induce
the lysis of M. smegmatis. However, it was unclear if lysis was a
direct result of inactivation/inhibition of InhA or an indirect
result caused by the inactivation of the FASII pathway. In
other words, it was not known whether the inactivation of
other FASII enzymes would also lead to lysis. Taking a genetic
approach to address the above question, we targeted the two
-ketoacyl–ACP synthases KasA and KasB, which catalyze the
first step of the reductive cycle. Our aim was to first determine
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whether kasA and kasB were essential in M. smegmatis. By
specialized transduction, a highly efficient phage-based allelic-
exchange method (3), kasB was shown to be nonessential for
the in vitro growth of M. smegmatis mc2155. This was consis-
tent with studies performed with Mycobacterium marinum (15).
In contrast, a specialized transducing phage designed to delete
kasA did not yield any transductants in M. smegmatis mc2155,
suggesting that kasA is essential for growth. To demonstrate
the essentiality of kasA, we developed a gene essentiality test-
ing method designated CESTET (conditional expression spe-
cialized transduction essentiality test). CESTET extends the
utility of the inducible acetamidase promoter (26, 29) by using
it in conjunction with specialized transduction. The validity of
the method was evaluated using the essential inhA gene, and
CESTET was then used to demonstrate the essentiality of kasA
by generating conditional null mutations in M. smegmatis. Con-
ditional depletion of KasA established that the effects of loss of
KasA were bactericidal.
MATERIALS AND METHODS
Plasmids, phages, and bacterial strains. Plasmids, phages, and bacterial
strains used in this study are outlined in Table 1. Strains of Mycobacterium
smegmatis were grown in tryptic soy broth (TSB; Difco) containing 0.05% Tween
80 (TSBT) or in Sauton medium. Escherichia coli strains were cultured in LB
broth. Solid media were made by adding 1.5% agar to the above-mentioned
broths. The concentrations of antibiotics used were 100 g/ml for hygromycin
and 20 g/ml for kanamycin with M. smegmatis and 150 g/ml for hygromycin
and 40 g/ml for kanamycin with E. coli.
Construction of merodiploid strains. The single-copy-integrating construct
pYUB2411 was constructed by ligating a 3.5-kb XbaI-ClaI fragment from plas-
mid pYUB2416 (containing the M. smegmatis inhA gene cloned in frame, down-
stream of the inducible M. smegmatis acetamidase promoter) into XbaI-ClaI-
digested pMV306. The M. tuberculosis kasA open reading frame was PCR
amplified from cosmid DNA using the primers KASA-L (GCGAGATCTGTG
ACCAGGCCTTCCACTG) and KASA-R (GCATTCGAATCAGTAACGCCC
GAATGC) and cloned into pCR2.1-TOPO (Invitrogen Life Technologies). The
plasmid pYUB2412 was constructed by simultaneous ligation of a 1.8-kb XbaI-
BamHI acetamidase promoter fragment and a BglII-HindIII kasA fragment
(pCR2.1-TOPO clone) into XbaI-HindIII-digested pMV306. Merodiploid
strains mc2155::pYUB2411 and mc2155::pYUB2412 were obtained by electro-
porating mc2155 with pYUB2411 and pYUB2412, respectively, and selecting for
kanamycin-resistant colonies.
Construction of deletion mutants. Approximately 1-kb sequences flanking the
left and right portions of the inhA gene were PCR amplified from M. smegmatis
genomic DNA using the primer pairs MSInh1 (GCAGATCTGATATCACGC
GAGCGTCGGCTGGC) and MSInh2 (TCTAGACTCGAGGCGGTCGAAAC
CGGTCAG) and MSInh3 (GCTCTAGAGCGATGAGCGCAATCGTG) and
MSInh4 (GCCCATGGATATCGTCGGCGACGAAGCCGAG), respectively.
Following cloning into pCR2.1-TOPO and sequencing, the cloned PCR frag-
ments were excised using the primer-introduced restriction sites and cloned into
the allelic-exchange plasmid vector pJSC347 (Table 1). The resultant plasmid,
pYUB2413, was then packaged into the temperature-sensitive phage phAE159
(J. Kriakov and W. R. Jacobs Jr., unpublished results) as described earlier (3) to
yield the knockout phage ph401. Knockout plasmids and phages for M.
smegmatis kasA (pYUB2414 and ph402) and kasB (pYUB2415 and
phAE403) were generated in a similar fashion. The primers pairs used for
amplification of 1 kb of sequences flanking kasA were KASA1 (GTCACTAG
TAGATCGTCGCC) and KASA2 (CTGTTCGAAACGCGGATACCGCTCTC
GCCG), and KASA3 (GACTCTAGACAGGTGAGCCTCGGTACG) and
KASA4 (TGCGGTACCGTGCCGGTCGCATGCGCG). The primers pairs used
for amplification of 1 kb of sequences flanking kasB were KASB1 (GATACT
TABLE 1. Plasmids, bacterial strains, and phages used in this study
Plasmid, strain, or phage Descriptiona Reference/source
Plasmids
pMV306 Kanr, single-copy-integrating vector; inserts into the phage L5
chromosomal integrating site attB in many mycobacteria
40
pCR2.1-TOPO PCR product cloning vector Invitrogen Life Technologies
pYUB2411 inhA cloned downstream of the acetamidase promoter in pMV306 This work
pYUB2412 kasA cloned downstream of the acetamidase promoter in pMV306 This work
pJSC347 Vector for cloning allelic-exchange substrates to be used for specialized
transduction; contains  phage cos site and Hygr marker
33
pYUB2413 Derivative of pJSC347 designed for allelic exchange of M. smegmatis inhA This work
pYUB2414 Derivative of pJSC347 designed for allelic exchange of M. smegmatis kasA This work
pYUB2415 Derivative of pJSC347 designed for allelic exchange of M. smegmatis kasB This work
pYUB2416 M. smegmatis inhA cloned into pSD26 (10), an expression vector with the
acetamidase promoter
Gift from C. Vilche`ze
Bacterial strains
mc2155 Electroporation-proficient ept mutant of M. smegmatis strain mc26 39
mc2155::pYUB411 Kanr mc2155 derivative containing pYUB2411 integrated into the attB site This work
mc2155::pYUB412 Kanr mc2155 derivative containing pYUB2412 integrated into the attB site This work
mc24751 Chromosomal copy of inhA in mc2155::pYUB2411 is replaced by a
hygromycin resistance cassette
This work
mc24752 Chromosomal copy of kasA in mc2155::pYUB2411 is replaced by a
hygromycin resistance cassette
This work
Phages
phAE159 Conditionally replicating shuttle phasmid derived from the lytic
mycobacteriophage TM4
Gift from J. Kriakov
phAE401 Derivative of phAE159 obtained by cloning pYUB2413 into its unique
PacI site
This work
phAE402 Derivative of phAE159 obtained by cloning pYUB2414 into its unique
PacI site
This work
phAE403 Derivative of phAE159 obtained by cloning pYUB2415 into its unique
PacI site
This work
a attB, phage L5 chromosomal integration site.
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AGTCAAGGTGTCGCCGCTCGC) and KASB2 (GCGTTCGAACTCTGGCC
GTCGAGCAGC) and KASB3 (GTATCTAGACCACGACAGGGCGATTAC)
and KASB4 (GCAGGTACCGGTTGTTGGCGATGACAC). Specialized trans-
duction was performed as described previously (3), except that for essential gene
testing, in which the host strains were the respective merodiploids and half the
transduction mix was spread on TSB agar plates containing kanamycin, hygro-
mycin, and 0.2% acetamide, while the other half was spread on plates lacking
acetamide.
Conditional depletion of InhA or KasA. Strains to be tested were grown in
TSBT containing 0.2% acetamide to an A600 of 0.5. The cells were washed twice
in TSBT to remove traces of acetamide and resuspended to the original volume
in TSBT. This cell suspension was used as a 20% inoculum in TSBT and grown
for 12 h to deplete intracellular InhA or KasA. The depleted culture was then
used to inoculate TSBT with or without 0.2% acetamide (5% inoculum). This
inoculation of the depleted culture corresponds to the 0-h time point for all
experiments designed to test cell density and viability and morphological changes
(see below). The same procedure was followed for a culture grown in Sauton
medium to test the biochemical effects of depletion.
Determination of viable-cell counts. For determining numbers of CFU, ali-
quots of cultures were serially diluted in TSBT (10-fold dilutions). The appro-
priate dilutions were then spread on TSB agar containing 0.2% acetamide, and
the plates were incubated at 37°C for 72 h before CFU were counted.
Western blotting. Following inoculation from a 12-h-depleted culture (see
above), bacterial cells were grown in Sauton medium in the absence or presence
of acetamide and harvested at different time points. The cell pellet was resus-
pended in 0.8 ml of phosphate-buffered saline (20 mM K2HPO4, pH 7.5, 0.15 M
NaCl) and disrupted for 10 min using a model 450 Branson sonifier. Protein
concentrations were determined using the BCA protein assay reagent kit
(Pierce), and equal amounts (20 g) were then separated on a 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gel. Proteins were then trans-
ferred onto a membrane, which was subsequently saturated with 2% bovine
serum albumin in phosphate-buffered saline containing 0.1% Tween 20. Mem-
branes were then probed with either rat anti-KasA antibodies (22) or rabbit
anti-InhA antibodies (21) and incubated with the appropriate alkaline phos-
phatase-conjugated antibodies.
In vivo effects of InhA or KasA depletion on mycolic acid synthesis. Using the
depleted culture grown for 12 h in Sauton medium without acetamide as the
inoculum (see above), cultures were grown in Sauton medium in the presence or
absence of acetamide. Aliquots were taken after 7 and 24 h and labeled with 1
Ci/ml of [1-14C]acetate (50 to 62 mCi/mmol; Amersham) for 3 h. Cells were
then harvested by centrifugation, washed with water, and stored at 20°C. Fatty
acid methyl esters (FAMEs) and mycolic acid methyl esters (MAMEs) were
obtained by treatment of the radiolabeled cell pellets with aqueous tetrabutyl
ammonium hydroxide, esterification with methyl iodide, and extraction with
dichloromethane as described previously (19). Equal counts (50,000) were spot-
ted on a thin-layer chromatography (TLC) plate, which was developed in petro-
leum ether-acetone (95%-5%, vol/vol) and exposed overnight to X-ray films.
Two-dimensional argentation TLC analysis of the 24-h samples was done as
described earlier (22).
SEM. Using the depleted culture grown for 12 h in TSBT without acetamide
as the inoculum (see above), samples for scanning electron microscopy (SEM)
were grown in TSBT (with or without acetamide) for 24 h. One milliliter of
culture was fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4,
applied to poly-L-lysine-coated coverslips, dehydrated through a graded series of
ethanol, critical point dried using liquid carbon dioxide in a model 790 Tousimis
Samdri (Rockville, Md.) critical point drier, and then sputter coated with gold-
palladium in a Denton (Cherry Hill, N.J.) vacuum desk-1 sputter coater. The
samples were examined in a JEOL (Peabody, Mass.) JSM6400 scanning electron
microscope using an accelerating voltage of 10 kV.
RESULTS
The kasA-encoded -ketoacyl–ACP synthase is essential in
M. smegmatis. Specialized transduction (3) of M. smegmatis
mc2155 with a temperature-sensitive phage containing an al-
lelic-exchange substrate designed to replace kasA with a hy-
gromycin resistance cassette (hyg) failed to yield any hygromy-
cin-resistant (Hygr) transductants (data not shown). This
negative result suggested that KasA is essential for the normal
growth of M. smegmatis. In contrast, the other -ketoacyl–ACP
synthase, KasB, is dispensable in M. smegmatis because null
mutants could be generated following specialized transduction
with the kasB phage phAE403 (data not shown). This result is
consistent with the reported nonessentiality on kasB in Myco-
bacterium marinum (15).
The failure to obtain kasA null mutants did not prove that
kasA is essential, nor did it allow us to study the fate of my-
cobacterial cells depleted of KasA. To achieve these objectives,
we developed a gene essentiality testing method that adapted
the inducible acetamidase promoter (26, 29) for use in con-
junction with specialized transduction. The gene essentiality
testing system was called CESTET to distinguish it from other
methods that make use of the acetamidase promoter (12, 17).
CESTET involves three steps: (i) the construction of a mero-
diploid strain containing a second copy of a putative essential
gene fused transcriptionally to the acetamidase promoter, (ii)
the generation of a specialized transducing phage containing
an allelic-exchange substrate designed to replace the target
gene with hyg, and (iii) transduction of the merodiploid strain
prior to growth in the presence or absence of acetamide (Fig. 1).
We first validated CESTET using inhA, a mycolic acid bio-
synthesis gene known to be essential (47). When transduced
with ph401, Hygr colonies of the inhA merodiploid strain
(mc2155::pYUB2411) could be obtained only if the transduc-
tion mix was plated on selective TSB agar containing 0.2%
acetamide (Fig. 2). Between 28 and 63 Hygr colonies were
obtained on acetamide-containing plates from four indepen-
dent transductions (average number of Hygr colonies, 41).
Southern blot analysis of genomic DNA from four indepen-
dent Hygr transductants selected from one transduction exper-
iment revealed replacement of the wild-type chromosomal
copy of inhA by hyg (Fig. 3a). [32P]dCTP-labeled probes de-
rived from the 1-kb flanking sequences hybridized with
9.3-kb and 11.7-kb BspHI bands in the parental merodiploid
strain, while as expected, all four Hygr transductants produced
a single BspHI band of 22.2 kb (Fig. 3a). One of the Hygr
transductants designated mc24751 was selected for further
work. Thus, the survival of cells that had undergone allelic
exchange to delete inhA was dependent on the acetamidase
promoter-driven expression of the extra copy of inhA, first,
confirming that inhA was an essential gene and second, vali-
dating the essentiality test.
When the kasA knockout phage ph402 was transduced
into the kasA merodiploid strain mc2155::pYUB2412, between
31 and 50 Hygr colonies (average number of Hygr colonies, 39)
were obtained on TSB agar plates containing acetamide from
four different transductions, but none were obtained on TSB
agar plates without acetamide (Fig. 2, bottom panels). South-
ern blot analysis confirmed replacement of the chromosomal
copy of kasA by hyg (Fig. 3b). [32P]dCTP-labeled probes de-
rived from 1-kb flanking sequences hybridized with a 6.7-kb
PstI band in the parental merodiploid strain and with two PstI
bands of sizes 2.3 kb and 5.3 kb in the three independent Hygr
transductants tested (Fig. 3b). One of the conditional kasA
deletion mutants, designated mc24752, was selected for further
work. No Hygr colonies were obtained when ph402 was
transduced into an mc2155 strain containing kasB cloned on an
autonomously replicating plasmid, indicating that extra copies
of kasB could not compensate for the loss of kasA (data not
shown). These results show that kasA is an essential gene in M.
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smegmatis and that KasA and KasB have nonredundant roles
in mycolic acid biosynthesis.
Conditional depletion of KasA is a bactericidal event that
leads to the lysis of M. smegmatis. Previous studies demon-
strated that the thermal inactivation of mutant InhA protein
led to cessation of mycolic acid synthesis, followed by cell lysis
(47). While thermal inactivation of a thermolabile enzyme
would be expected to inactivate every molecule of the mutated
peptide at the nonpermissive temperature, observing the ef-
fects of conditional depletion of a protein would require turn-
over and a dilution of existing functional protein. To achieve
this, the conditional inhA mutant mc24751 was grown to mid-
log phase (12 h) in the absence of acetamide, prior to inocu-
lation in medium with or without acetamide. Optical density
(OD) measurements revealed normal growth kinetics for
mc24751 cells grown in acetamide-containing medium. How-
ever, mc24751 cells cultured in the absence of acetamide
showed a decrease in OD after 12 h of growth. After 18 h there
was clearing in the growth medium accompanied by an accu-
mulation of debris indicating cell lysis (Fig. 4 inset). This de-
crease in OD correlated with a decrease in intracellular levels
of InhA (Fig. 5a) as well as a decrease in the number of CFU
(Fig. 4a). Thus, InhA depletion had the same effect as INH
treatment or thermal inactivation on a thermolabile mutant
InhA.
We then analyzed the growth kinetics of the conditional
kasA mutant mc24752. Growth in the absence of acetamide
resulted in the loss of KasA (Fig. 5b), which correlated with a
drop in the OD and a decrease in numbers of CFU (Fig. 4b).
At 18 h, the culture showed complete lysis (Fig. 4b, insets).
This result established that depletion of KasA was sufficient for
the lysis of M. smegmatis.
Conditional depletion of InhA or KasA leads to different
biochemical and morphological phenotypes prior to lysis. An
understanding of the biochemical and morphological events
that precede mycobacterial cell lysis might lead to ways to
augment lytic pathways. Phenotypes of lysing mycobacterial
cells have been described in detail for mycobacteria treated
with INH (1, 21, 43, 44, 47). Previous studies have shown that
INH treatment correlates with (i) inhibition of mycolic acid
FIG. 1. Schematic representation of CESTET. Following the injection of recombinant phage DNA into a merodiploid strain, allelic exchange
mediated by recombination of homologous sequences (regions in gray) results in deletion of the natural copy of a putative essential gene (peg).
The transduction mix is split into two equal parts, which are plated on hygromycin-containing medium with or without acetamide. If the gene is
essential, transductants are expected to grow only on plates containing acetamide. attL and attR, left and right junctions of the phage L5 attachment
and chromosomal integration site; kan, kanamycin resistance cassette; hyg, hygromycin resistance cassette; Hyg, hygromycin; Pacetamidase, inducible
acetamidase promoter. The interrupted arc represents the integrative vector, the solid arc represents the mc2155 chromosome, and the dotted
strand represents phage DNA.
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biosynthesis, (ii) accumulation of an 80-kDa complex contain-
ing both KasA and AcpM, and (iii) formation of blebs on the
cell surface, followed by cell lysis (21, 28, 41, 43, 44). Although
depletion of KasA also led to cell lysis, it was unclear whether
morphological and biochemical phenotypes prior to lysis were
similar to those described for INH treatment. We thus com-
pared the effects of KasA depletion to those of InhA depletion
by monitoring the above correlates of INH treatment.
An 80-kDa KasA-containing complex was induced when M.
smegmatis was grown in the presence of InhA-inhibitory drugs,
including INH (21), but not in the presence of thiolactomycin
(TLM), a known inhibitor of KasA (19, 38). Moreover, several
InhA(Ts) mutant strains of M. smegmatis constitutively ex-
pressed the KasA-containing complex, suggesting that a defect
of InhA activity induces this complex (21). Both mc24751 and
mc24752 were tested for induction of the KasA-containing
complex following growth in medium lacking acetamide. West-
ern blots using anti-M. tuberculosis KasA antibodies showed
that a basal level of the complex was preexistent in both strains
(Fig. 6, lanes with acetamide). This finding was not unusual, as
the KasA-containing complex has been detected before in un-
treated mycobacteria, suggesting a physiological role (21). The
levels of the KasA-containing complex increased in mc24751
within 6 h of growth in medium without acetamide (Fig. 6a)
but remained steady in cultures grown in the presence of ac-
etamide. In contrast, there was no induction of the KasA-
containing complex in mc24752 cells grown in the absence of
acetamide (Fig. 6b). Induction of the 80-kDa complex in the
conditional kasA mutant would be expected to manifest in a
fashion where the decrease in levels of free KasA would be
faster than the decrease in levels of the KasA-containing com-
plex. This was not the case, as the Western blot of mc24752
cells cultured in medium without acetamide showed a propor-
tional decrease in the levels of free KasA and the 80-kDa
complex (Fig. 6b). The anti-KasA antibody also cross-reacted
with the second ketoacyl-ACP synthase, KasB, a protein highly
related to KasA (19, 36) and present in the crude lysates from
mc24751 and mc24752. Although kasA and kasB are adjacent
genes from the same operon, this result indicates that deletion
of kasA did not have a polar effect on kasB expression. More-
over, Western blots using anti-M. tuberculosis InhA antibodies
demonstrated that the loss of KasA does not alter InhA ex-
pression (Fig. 6b) and, conversely, that depletion of InhA does
not affect the expression level of free KasA (Fig. 6a).
The levels of mycolic acid biosynthesis were monitored at
different time intervals with mc24751 and mc24752 following
growth in medium with or without acetamide. Cultures were
pulsed with [14C]acetate at different time intervals after inoc-
ulation in medium, and MAMEs were extracted and analyzed
by TLC. Both mutant strains showed a strong decrease in levels
of 	 and epoxy mycolic acids (Fig. 7) when grown in medium
lacking acetamide. In contrast, there was an accumulation of
	
-mycolates in both mc24751 and mc24752. This was more
distinct in the kasA mutant, presumably because of the faster
lysis of the kasA mutant. Prolonged treatment of M. smegmatis
mc2155 with INH showed that the drug had a similar effect
FIG. 2. CESTET to demonstrate the essentiality of M. smegmatis inhA (top panels) or kasA (bottom panels). Transduction mixes (109 CFU
mixed with 1010 PFU) are indicated on the left. Each mix was split equally and plated out on hygromycin-containing TSB agar with (left panels)
or without (right panels) acetamide. Each plate represents one-fourth of the transduction mix. Hygr colonies can be seen only on acetamide-
containing plates.
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FIG. 3. Southern blots confirming the deletion of inhA (a) and kasA (b) in mc2155::pYUB2411 and mc2155::pYUB2412, respectively. The
adjoining maps show the expected band sizes, and the regions used as probes are indicated as thick lines with square ends. The probes used for
each blot were the same (1 kb) upstream and downstream flanking sequences that were used to construct the knockout plasmids. Only one
representative band pattern is shown for each mutant strain. For the inhA region, the probes were expected to hybridize with 9.3-kb and 11.7-kb
BspHI bands in the parental merodiploid strain and a single BspHI band of 22.2 kb in the inhA mutant mc24751. For the kasA region, probes were
expected to hybridize with a 6.7-kb PstI band in the parental merodiploid strain and with two PstI bands of sizes 2.3 kb and 5.3 kb in the kasA
mutant mc24752. res,  resolvase site; hyg, hygromycin resistance gene.
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(data not shown). Similarly, treatment of M. smegmatis with
TLM, a known KasA inhibitor (19, 38), was also accompanied
by an accumulation of 	
-mycolates (38). Overall, these results
indicate that the observed accumulation of 	
-mycolates seems
to be a general outcome of the loss of FASII activity in M.
smegmatis. Further analysis of the mycolates by two-dimen-
sional argentation TLC to detect changes in the degrees of
unsaturation did not reveal any major differences (data not
shown).
Previous studies demonstrated that InhA inactivation, like
INH treatment, led to the generation of blebs on the surfaces
of bacteria (47). SEMs revealed that conditional depletion of
InhA led to extensive bleb formation (Fig. 8b, c, and d). Ap-
proximately 77% of the bacteria observed in a total of 20 fields
had blebs. In contrast, conditional depletion of KasA in
mc24752 resulted in the cells having an irregular surface with a
“crumpled” appearance (Fig. 8f, g, and h). Approximately 84%
of the bacteria observed in a total of 20 fields had a “crumpled”
appearance. Cells from 24-h cultures of both mutants grown in
the presence of acetamide had a normal appearance (Fig. 8a
and e). These results indicate that depletion of InhA or KasA
resulted in very different morphological changes in the bacteria
prior to lysis.
DISCUSSION
In this study, we have demonstrated the essentiality of the
FASII component KasA. Furthermore, this is the first descrip-
tion of the effects of depletion of KasA in a mycobacterial cell.
We developed a conditional essentiality testing method to
demonstrate the essentiality of inhA and kasA in M. smegmatis
and then followed the fates of the two mutants by culturing
them in medium without acetamide, which resulted in the
depletion of InhA or KasA.
While the depletion of either InhA or KasA led to the lysis
of mycobacterial cells, the patterns of lysis were profoundly
different for the two strains. Growth of wild-type M. smegmatis
in the presence of INH induces the formation of an 80-kDa
KasA-containing complex and causes the appearance of blebs
on the cell surface, which leads to cell lysis (21, 47). Similar
features were observed when the conditional inhA mutant
mc24751 was grown in the absence of acetamide, indicating
FIG. 4. Plot of numbers of CFU obtained from cultures of mc24751
(a) and mc24752 (b) grown in TSBT with or without acetamide, taken
at different time points. Log10 CFU values are calculated from differ-
ent dilutions from a single experiment. The insets placed next to the
18-h data points show pictures of the cultures after 18 h of growth in
TSBT with or without acetamide. Repetition of the experiment gave
similar results (data not shown).
FIG. 5. Western blots of total crude lysates from mc24751 (a) and
mc24752 (b) grown in the absence or presence of acetamide to detect
intracellular levels of InhA (a) or KasA (b) using rabbit anti-InhA or
rat anti-KasA antibodies, respectively.
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that InhA depletion mimicked InhA inhibition. In contrast,
conditional depletion of KasA in mc24752 led to different phe-
notypes: there was no induction of the KasA-containing com-
plex and bacterial cells had a crumpled surface appearance
prior to lysis. However, in terms of the effects of InhA and
KasA depletion on mycolic acid synthesis, the phenotypes ap-
peared comparable. Both strains showed a decrease in the
levels of 	- and epoxy mycolates, with a concomitant accumu-
lation of 	
-mycolates, a feature that has been reported to
occur in TLM-treated cells (38).
Our studies also demonstrated that while KasA is essential,
the second -ketoacyl-ACP synthase, KasB, is not an essential
component of the FASII machinery. A null kasB mutant was
generated from a wild-type M. smegmatis strain (mc2155), sug-
gesting that KasB is not required for normal growth in vitro.
This is consistent with the recent observation that a transposon
insertion in kasB was not lethal in Mycobacterium marinum
(15). In agreement with Gao et al. (15), we found that multiple
copies of KasB could not compensate for the loss of KasA in
M. smegmatis, demonstrating that although the two ketosyn-
thases are highly homologous, they do not share redundant
functions.
Bacterial cell lysis may not be a direct effect of cessation of
mycolic acid biosynthesis. Liu and Nikaido (24) used chemical
mutagenesis to isolate a temperature-sensitive mutant of M.
smegmatis that was unable to synthesize complete mycolic ac-
ids but was still viable at 30°C. The mutant strain failed to
synthesize full-length mycolates but accumulated incomplete
meromycolate chains with a -hydroxyl group, leading to spec-
ulation that the mutation was in the yet-unidentified dehy-
dratase-encoding gene. In addition, this mutant had a cell wall
with an abnormal composition and ultrastructure (24, 48).
Thus, the lysis observed with the conditional inhA and kasA
mutants may not necessarily be a direct consequence of cell
wall damage. Rather, depletion of InhA or KasA may be re-
sponsible for changes in cellular metabolic processes, which in
turn lead to the induction of specific genes causing bacterial
cell death. Indeed, this is the case in Streptococcus pneumoniae,
in which specific autolysins are induced following penicillin
treatment (25, 46). Moreover, the different cell morphologies
prior to lysis suggest that the two mutants may have activated
different cell death-inducing pathways. In this regard, it has
been shown using the DNA microarray technology that al-
though numerous genes were commonly regulated in M. tuber-
culosis treated with INH or TLM (inhibiting InhA and KasA,
respectively), there were differences that distinguish the modes
of action of these two drugs (5). Therefore, the signature gene
expression profiles that discriminate between INH- and TLM-
treated mycobacteria may help to identify cell death-inducing
genes that are specifically activated following InhA or KasA
depletion. A better understanding of these events leading to
cell death should allow for the design of compounds that would
augment the mycobacterial-killing process. Such compounds
could also act synergistically with existing antimicrobials.
To justify high-throughput screening of combinatorial librar-
ies for antimicrobials, it is imperative to characterize an essen-
tial gene product as a putative drug target. Furthermore,
FIG. 6. Western blots of total crude lysates from mc24751 (a) and
mc24752 (b) to detect the formation of the KasA-containing 80-kDa
complex. Detection of KasA and InhA in total protein extracts was
performed using rat anti-KasA and rabbit anti-InhA antibodies, whose
masses are indicated on the left side of each panel.
FIG. 7. Thin-layer chromatography of 14C-labeled methyl esters of
mycolic acids extracted following depletion of InhA or KasA. Culture
aliquots of mc24751 and mc24752 were labeled by the addition of
[1-14C] acetate (1 Ci/ml) at various time points during growth in the
absence or presence of acetamide at 37°C. The control strain, mc2155,
was left untreated or treated with 25 g/ml INH for 3 h. MAMEs and
FAMEs were extracted, and equal counts (50,000) were loaded on the
TLC plate. Separation was performed as described in Materials and
Methods. 	, 	
, and e correspond to 	-mycolates, 	
-mycolates, and
epoxy mycolates, respectively.
VOL. 187, 2005 DEPLETION OF KasA LEADS TO LYSIS IN MYCOBACTERIA 7603
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
FIG. 8. Scanning electron micrographs of mc24751 (a, b, c, and d) and mc24752 (e, f, g, and h). (a and e) Cultures grown for 24 h in the presence
of acetamide; (b, c, d, f, g, and h) cultures grown for 24 h in the absence of acetamide. All scale bars represent 0.5 m.
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screening of natural products against a specific target would
also require target validation. The demonstration in our stud-
ies that the depletion of KasA leads to mycobacterial cell lysis
reiterates the importance of TLM and its analogues for future
antitubercular therapy (11, 19) and highlights the potential of
KasA as an attractive target to be explored for the design of
novel drugs.
An additional benefit from our studies was the validation of
a gene essentiality testing system that could be used for study-
ing other mycobacterial genes. While transposon mutant
screens have identified numerous essential genes (23, 34, 35),
they do not provide rigorous proof of the essentiality of indi-
vidual genes. Data obtained from transposon mutagenesis ex-
periments also do not help distinguish between bacteriostatic
and bactericidal effects of gene disruption. Conditional deple-
tion of an essential gene product using CESTET overcomes
these limitations. Gomez and Bishai (17) used the chemically
inducible acetamidase promoter to establish that WhmD is
essential for M. smegmatis and leads to filamentous growth
upon its conditional depletion. A similar approach was used to
follow the fate of cells depleted of FtsZ (12). However, the
methods used involved generation of a strain with a single
crossover, followed by screening of the second crossover event.
We have improved on the utility of the acetamidase promoter
to test gene essentiality by combining it with specialized trans-
duction to demonstrate essentiality in a one-step plate assay.
Using the inhA or kasA knockout phages, we consistently ob-
tained scores of independent transductants on plates with ac-
etamide, indicating that the method was reliable for testing
gene essentiality. There has been one report to date which
describes the inducibility of the M. smegmatis acetamidase
promoter in M. tuberculosis and Mycobacterium bovis BCG
(27), so it is likely that the essentiality test can also be adapted
for use in these slow-growing mycobacteria. Recently, the tet-
racycline repressor (TetR) and operator (tetO)-based system
has been used for generating conditional knockouts of essen-
tial genes in M. smegmatis and for conditional, in vivo expres-
sion in M. tuberculosis (7, 13). Adapting CESTET to use the
TetR-tetO system could potentially extend the system for use
with slow growers. An added advantage is that gene knockouts
are generated using a temperature-sensitive shuttle phasmid
(3, 4, 8, 18) derived from the lytic phage TM4 (45), which has
a wide host range within mycobacterial species (14), allowing
the method to be easily adapted to other mycobacteria. In
addition, in slow-growing mycobacteria, illegitimate recombi-
nation events commonly encountered with electroporation-
based DNA delivery are rarely observed with specialized trans-
duction (3). Our studies also demonstrate that CESTET can be
used to validate drug targets, as conditional depletion of a
putative target of an antimicrobial drug would be expected to
cause phenotypes similar to those seen on treatment of wild-
type bacteria with the drug. Moreover, the robustness of spe-
cialized transduction makes this system amenable to a high-
throughput, whole-genome approach.
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